Results 21 to 30 of about 51,875 (217)

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Emerging Infectious Diseases, 2002
Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family ...
Francis Drobniewski, Yanina Balabanova, Michael Ruddy, Laura Weldon, Katya Jeltkova, Timothy Brown, Nadezdna Malomanova, Elvira Elizarova, Alexander Melentyey, Ebgeny Mutovkin, Svetlana Zhakharova, Ivan Fedorin   +11 more
doaj   +1 more source

Effect of the nanoliposomal formulations of rifampin and N-acetyl cysteine on staphylococcus epidermidis biofilm [PDF]

Nanomedicine Journal, 2020
Objective(s): Staphylococcus epidermidis is a common cause of medical device-associated infections due to biofilm formation, and its elimination is extremely challenging. Although rifampin efficacy against S.
Farzaneh Bazrgari, Bahman Khameneh, Bibi Sedigheh Fazly Bazzaz, Asma Mahmoudi, Bizhan Malaekeh-Nikouei   +4 more
doaj   +1 more source

Radical Scavenging of Poly(Methyl Methacrylate) Bone Cement by Rifampin and Clinically Relevant Properties of the Rifampin-Loaded Cement [PDF]

, 2019
Objectives: The objective of this study was to characterize the effect of rifampin incorporation into poly(methyl methacrylate) (pMMA) bone cement. While incompatibilities between the two materials have been previously noted, we sought to identify and ...
Menuey, E. M., Schuman, Thomas P., Mciff, T. E., Cole, K. A., Funk, G. A., Kilway, K. V.   +5 more
core   +1 more source

Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR), rifampin resistant (RR) and isoniazid (INH) resistant Mycobacterium tuberculosis isolates.

, 2022
Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR), rifampin resistant (RR) and isoniazid (INH) resistant Mycobacterium tuberculosis isolates.
Russell R. Kempker (7348955), Gobena Ameni (357071), Dereje Beyene (5334734), Henry M. Blumberg (7348961), Muluwork Getahun (6744347)   +4 more
core   +1 more source

Influence of Rifampin Therapy on Serum Bactericidal Activity in the Presence of Cloxacillin and Vancomycin

Canadian Journal of Infectious Diseases, 1990
In this study the effect of rifampin on serum inhibitory and serum bactericidal titres was examined. Sera were prepared from pooled human serum to contain vancomycin (10 mg/L), cloxacillin (5 mg/L) or rifampin (1 mg/L), and the combinations cloxacillin ...
Andrew MR Mackenzie, Noni E MacDonald
doaj   +1 more source

Innovative methods for the diagnosis and treatment of implant-associated infections [PDF]

, 2009
Indwelling devices and prosthesis are increasingly used in modern medicine practices. Failures of prosthetic joint devices constitute an important complication. Especially, the management of patients with a septic failure is characterized by difficulties
Baldoni, Daniela
core   +1 more source

Minimum inhibitory concentration of rifampin, rifabutin, and isoniazid

, 2022
 The minimum inhibitory concentration of rifampin, rifabutin, and isoniazid among multidrug-resistant (MDR), rifampin-resistant (RR), and isoniazid (INH) resistant Mycobacterium tuberculosis isolate stratified by line probe assay result. 
Russell R. Kempker (333422), Muluwork Getahun (12531040), Gobena Ameni (357071), Henry M. Blumberg (333428), Dereje Beyene (5334734)   +4 more
core   +1 more source

Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor

Scientific Reports, 2022
Milvexian (BMS-986177/JNJ-70033093) is a potent, oral small molecule that inhibits the active form of factor XI with high affinity and selectivity.
Vidya Perera, Zhaoqing Wang, Susan Lubin, Lisa J. Christopher, Wei Chen, Sophia Xu, Dietmar Seiffert, Mary DeSouza, Bindu Murthy   +8 more
doaj   +1 more source

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients

Pediatric Reports, 2022
Myelosuppression, a potential adverse reaction of nafcillin and rifampin, is rarely documented in pediatric populations. The objective of this study is to describe the incidence of myelosuppression in pediatric patients receiving nafcillin or a ...
Jolly Kuriakose, Michelle Kaplansky, Caroline M. Sierra   +2 more
doaj   +1 more source

High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis

The Journal of Clinical Investigation, 2022
Tuberculous meningitis (TB meningitis) is the most severe form of tuberculosis (TB), requiring 12 months of multidrug treatment for cure, and is associated with high morbidity and mortality.
Camilo A. Ruiz-Bedoya, Filipa Mota, Elizabeth W. Tucker, Farina J. Mahmud, Maria I. Reyes-Mantilla, Clara Erice, Melissa Bahr, Kelly Flavahan, Patricia de Jesus, John Kim, Catherine A. Foss, Charles A. Peloquin, Dima A. Hammoud, Alvaro A. Ordonez, Carlos A. Pardo, Sanjay K. Jain   +15 more
doaj   +1 more source